Morbidity of antireflux surgery in lung transplant and matched nontransplant cohorts is comparable.

Szczegóły
Abstrakt

Tytuł:: Morbidity of antireflux surgery in lung transplant and matched nontransplant cohorts is comparable.
Autorzy:: Razia D; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, 500 W Thomas Rd, Suite 500, Phoenix, AZ, 85013, USA.; Creighton University School of Medicine - Phoenix Regional Campus, Phoenix, AZ, USA.
Mittal SK; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, 500 W Thomas Rd, Suite 500, Phoenix, AZ, 85013, USA. .; Creighton University School of Medicine - Phoenix Regional Campus, Phoenix, AZ, USA. .
Walia R; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, 500 W Thomas Rd, Suite 500, Phoenix, AZ, 85013, USA.; Creighton University School of Medicine - Phoenix Regional Campus, Phoenix, AZ, USA.
Tokman S; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, 500 W Thomas Rd, Suite 500, Phoenix, AZ, 85013, USA.; Creighton University School of Medicine - Phoenix Regional Campus, Phoenix, AZ, USA.
Huang JL; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, 500 W Thomas Rd, Suite 500, Phoenix, AZ, 85013, USA.; Creighton University School of Medicine - Phoenix Regional Campus, Phoenix, AZ, USA.
Smith MA; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, 500 W Thomas Rd, Suite 500, Phoenix, AZ, 85013, USA.; Creighton University School of Medicine - Phoenix Regional Campus, Phoenix, AZ, USA.
Bremner RM; Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, 500 W Thomas Rd, Suite 500, Phoenix, AZ, 85013, USA.; Creighton University School of Medicine - Phoenix Regional Campus, Phoenix, AZ, USA.
Źródło:: Surgical endoscopy [Surg Endosc] 2023 Feb; Vol. 37 (2), pp. 1114-1122. Date of Electronic Publication: 2022 Sep 21.
Typ publikacji:: Journal Article
Język:: English
Imprint Name(s):: Publication: 1992- : New York : Springer
Original Publication: [Berlin] : Springer International, c1987-
MeSH Terms:: Gastroesophageal Reflux*/surgery
Lung Transplantation*
Laparoscopy*
Adult ; Humans ; Postoperative Complications/epidemiology ; Morbidity ; Fundoplication ; Treatment Outcome
References:: Verleden GM, Glanville AR, Lease ED, Fisher AJ, Calabrese F, Corris PA, Ensor CR, Gottlieb J, Hachem RR, Lama V, Martinu T, Neil DAH, Singer LG, Snell G, Vos R (2019) Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT. J Heart Lung Transplant 38:493–503. (PMID: 10.1016/j.healun.2019.03.00930962148)
Masuda T, Mittal SK, Kovács B, Smith MA, Walia R, Huang JL, Bremner RM (2019) Foregut function before and after lung transplant. J Thorac Cardiovasc Surg 158:619–629. (PMID: 10.1016/j.jtcvs.2019.02.12831084982)
Sharma M, Ravichandran R, Perincheri S, Danziger-Isakov L, Heeger PS, Sweet SC, Mohanakumar T (2020) Distinct molecular and immunological properties of circulating exosomes isolated from pediatric lung transplant recipients with bronchiolitis obliterans syndrome—a retrospective study. Transpl Int 33:1491–1502. (PMID: 10.1111/tri.1372033448479)
Fisichella PM, Davis CS, Lowery E, Pittman M, Gagermeier J, Love RB, Kovacs EJ (2012) Pulmonary immune changes early after laparoscopic antireflux surgery in lung transplant patients with gastroesophageal reflux disease. J Surg Res 177:e65-73. (PMID: 10.1016/j.jss.2012.03.066225378413694396)
Burton PR, Button B, Brown W, Lee M, Roberts S, Hassen S, Bailey M, Smith A, Snell G (2009) Medium-term outcome of fundoplication after lung transplantation. Dis Esophagus 22:642–648. (PMID: 10.1111/j.1442-2050.2009.00980.x19515194)
Lau CL, Palmer SM, Howell DN, McMahon R, Hadjiliadis D, Gaca J, Pappas TN, Davis RD, Eubanks S (2002) Laparoscopic antireflux surgery in the lung transplant population. Surg Endosc 16:1674–1678. (PMID: 10.1007/s00464-001-8251-212140642)
Anvari M, Allen C, Marshall J, Armstrong D, Goeree R, Ungar W, Goldsmith C (2011) A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for the treatment of patients with chronic gastroesophageal reflux disease (GERD): 3-year outcomes. Surg Endosc 25:2547–2554. (PMID: 10.1007/s00464-011-1585-521512887)
Galmiche JP, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, Långström G, Lind T, Lundell L (2011) Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA 305:1969–1977. (PMID: 10.1001/jama.2011.62621586712)
Grant AM, Cotton SC, Boachie C, Ramsay CR, Krukowski ZH, Heading RC, Campbell MK (2013) Minimal access surgery compared with medical management for gastro-oesophageal reflux disease: five year follow-up of a randomised controlled trial (REFLUX). BMJ 346:f1908. (PMID: 10.1136/bmj.f1908235993183629902)
Grant AM, Wileman SM, Ramsay CR, Mowat NA, Krukowski ZH, Heading RC, Thursz MR, Campbell MK (2008) Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial. BMJ 337:a2664. (PMID: 10.1136/bmj.a2664190749462603580)
Hatlebakk JG, Zerbib F, des Bruley Varannes S, Attwood SE, Ell C, Fiocca R, Galmiche JP, Eklund S, Långström G, Lind T, Lundell LR (2016) Gastroesophageal acid reflux control 5 years after antireflux surgery, compared with long-term esomeprazole therapy. Clin Gastroenterol Hepatol 14:678–685. (PMID: 10.1016/j.cgh.2015.07.02526226096)
Lundell L, Miettinen P, Myrvold HE, Hatlebakk JG, Wallin L, Engström C, Julkunen R, Montgomery M, Malm A, Lind T, Walan A (2009) Comparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitis. Clin Gastroenterol Hepatol 7:1292–1298 (quiz 1260). (PMID: 10.1016/j.cgh.2009.05.02119490952)
Lundell L, Miettinen P, Myrvold HE, Pedersen SA, Liedman B, Hatlebakk JG, Julkonen R, Levander K, Carlsson J, Lamm M, Wiklund I (2001) Continued (5-year) followup of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. J Am Coll Surg 192:172–179 (discussion 179-181). (PMID: 10.1016/S1072-7515(00)00797-311220717)
Mahon D, Rhodes M, Decadt B, Hindmarsh A, Lowndes R, Beckingham I, Koo B, Newcombe RG (2005) Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal reflux. Br J Surg 92:695–699. (PMID: 10.1002/bjs.493415898130)
Mehta S, Bennett J, Mahon D, Rhodes M (2006) Prospective trial of laparoscopic nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: Seven-year follow-up. J Gastrointest Surg 10:1312–1316 (discussion 1316-1317). (PMID: 10.1016/j.gassur.2006.07.01017114017)
Parrilla P, Martínez de Haro LF, Ortiz A, Munitiz V, Molina J, Bermejo J, Canteras M (2003) Long-term results of a randomized prospective study comparing medical and surgical treatment of Barrett’s esophagus. Ann Surg 237:291–298. (PMID: 10.1097/01.SLA.0000055269.77838.8E126161111514316)
Spechler SJ, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, Raufman JP, Sampliner R, Schnell T, Sontag S, Vlahcevic ZR, Young R, Williford W (2001) Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 285:2331–2338. (PMID: 10.1001/jama.285.18.233111343480)
Kahrilas PJ, Bredenoord AJ, Fox M, Gyawali CP, Roman S, Smout AJ, Pandolfino JE (2015) The Chicago classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil 27:160–174. (PMID: 10.1111/nmo.1247725469569)
Schober P, Mascha EJ, Vetter TR (2021) Statistics From A (Agreement) to Z (z Score): a guide to interpreting common measures of association, agreement, diagnostic accuracy, effect size, heterogeneity, and reliability in medical research. Anesth Analg 133:1633–1641. (PMID: 10.1213/ANE.000000000000577334633993)
Fisichella PM, Davis CS, Gagermeier J, Dilling D, Alex CG, Dorfmeister JA, Kovacs EJ, Love RB, Gamelli RL (2011) Laparoscopic antireflux surgery for gastroesophageal reflux disease after lung transplantation. J Surg Res 170:e279-286. (PMID: 10.1016/j.jss.2011.05.038218164223686158)
Davis CS, Jellish WS, Fisichella PM (2010) Laparoscopic fundoplication with or without pyloroplasty in patients with gastroesophageal reflux disease after lung transplantation: how I do it. J Gastrointest Surg 14:1434–1441. (PMID: 10.1007/s11605-010-1233-8204992013066265)
Pegna V, Mickevičius A, Tsang C (2014) How useful is antireflux surgery in lung transplant patients with gastroesophageal reflux? Medicina 50:318–322. (PMID: 10.1016/j.medici.2014.11.00625541263)
Robertson AG, Krishnan A, Ward C, Pearson JP, Small T, Corris PA, Dark JH, Karat D, Shenfine J, Griffin SM (2012) Anti-reflux surgery in lung transplant recipients: outcomes and effects on quality of life. Eur Respir J 39:691–697. (PMID: 10.1183/09031936.0006181121778169)
O’Halloran EK, Reynolds JD, Lau CL, Manson RJ, Davis RD, Palmer SM, Pappas TN, Clary EM, Eubanks WS (2004) Laparoscopic Nissen fundoplication for treating reflux in lung transplant recipients. J Gastrointest Surg 8:132–137. (PMID: 10.1016/j.gassur.2003.10.101314746846)
Abbassi-Ghadi N, Kumar S, Cheung B, McDermott A, Knaggs A, Zacharakis E, Moorthy K, Carby M, Hanna GB (2013) Anti-reflux surgery for lung transplant recipients in the presence of impedance-detected duodenogastroesophageal reflux and bronchiolitis obliterans syndrome: a study of efficacy and safety. J Heart Lung Transplant 32:588–595. (PMID: 10.1016/j.healun.2013.02.00923540400)
Contributed Indexing:: Keywords: Gastroesophageal reflux; Laparoscopic antireflux surgery; Lung transplantation; Morbidity; Readmissions; Safety
Entry Date(s):: Date Created: 20220921 Date Completed: 20230224 Latest Revision: 20230510
Update Code:: 20240105
PubMed Central ID:: PMC9491650
DOI:: 10.1007/s00464-022-09598-9
PMID:: 36131161
: Czasopismo naukowe

Full Text Finder

Background: Safety data on perioperative outcomes of laparoscopic antireflux surgery (LARS) after lung transplantation (LT) are lacking. We compared the 30-day readmission rate and short-term morbidity after LARS between LT recipients and matched nontransplant (NT) controls.
Methods: Adult patients who underwent LARS between January 1, 2015, and October 31, 2021, were included. The participants were divided into two groups: LT recipients and NT controls. First, we compared 30-day readmission rates after LARS between the LT and NT cohorts. Next, we compared 30-day morbidity after LARS between the LT cohort and a 1-to-2 propensity score-matched NT cohort.
Results: A total of 1328 patients (55 LT recipients and 1273 NT controls) were included. The post-LARS 30-day readmission rate was higher in LT recipients than in the overall NT controls (14.5% vs. 2.8%, p < 0.001). Compared to matched NT controls, LT recipients had a lower prevalence of paraesophageal hernia, a smaller median hernia size, and higher peristaltic vigor. Also compared to the matched NT controls, the LT recipients had a lower median operative time but a longer median length of hospital stay. The proportion of patients with a post-LARS event within 30 postoperative days was comparable between the LT and matched NT cohorts (21.8% vs 14.5%, p = 0.24).
Conclusions: Despite a higher perceived risk of comorbidity burden, LT recipients and matched NT controls had similar rates of post-LARS 30-day morbidity at our large-volume center with expertise in transplant and foregut surgery. LARS after LT is safe.
(© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)

Informacja